425: Churchill X Shareholders Approve Infleqtion Merger, Securing $550M+

Churchill Capital Corp X shareholders overwhelmingly approved the business combination with quantum technology leader Infleqtion, securing over $550 million in gross proceeds.

Summary

• Shareholders of Churchill Capital Corp X (CCCX) approved the business combination with ColdQuanta, Inc. (d/b/a Infleqtion) at an extraordinary general meeting on February 12, 2026.
• All proposals, including the Business Combination, Domestication, Organizational Documents, Stock Issuance, Incentive Plan, ESPP, and Director Election Proposals, received overwhelming shareholder support.
• Only 37,821 Class A Ordinary Shares, representing approximately 0.09% of outstanding Class A shares, were redeemed, resulting in only $388,453.90 being removed from the trust account.
• The transaction is expected to deliver approximately $551.4 million in gross transaction proceeds to Infleqtion, comprising $424.8 million from the trust account and $126.5 million from a private placement (PIPE).
• Churchill's jurisdiction will change from the Cayman Islands to Delaware, and the combined entity will be renamed Infleqtion, Inc.
• Infleqtion, Inc. common stock and warrants are expected to be listed on the New York Stock Exchange (NYSE) under ticker symbols INFQ and INFQ WS, respectively, starting February 17, 2026, following delisting from Nasdaq.
• The closing of the Business Combination is expected to occur promptly, likely on February 13, 2026.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a highly positive development, given the overwhelming shareholder approval, exceptionally low redemptions, and substantial capital infusion, which significantly de-risks the immediate post-merger period for Infleqtion.

Positives

• Overwhelming shareholder approval for the business combination and all related proposals, with over 90% of votes cast in favor.
• Nearly 100% of the cash held in Churchill X's trust account was retained, with a very low redemption rate of approximately 0.09% of Class A Ordinary Shares.
• Infleqtion is expected to receive over $550 million in gross proceeds, including $424.8 million from the trust account and $126.5 million from a common stock PIPE.
• The strengthened balance sheet is expected to accelerate Infleqtion's technology roadmap and product commercialization, expanding deployments across artificial intelligence, national security, and space.
• Infleqtion will become the first publicly listed neutral-atom quantum technology company and the only public company with commercial leadership across both quantum computing and precision sensing.
• The post-combination company, Infleqtion, Inc., will be listed on the New York Stock Exchange (NYSE) under the symbol INFQ, enhancing visibility and liquidity.

Risks

• Infleqtion is pursuing an emerging technology, faces significant technical challenges, and may not achieve commercialization or market acceptance.
• Infleqtion has a history of net losses and a limited operating history.
• Uncertainty regarding future financial performance, capital requirements, and unit economics.
• Dependence on members of senior management and the ability to attract and retain qualified personnel.
• Concentration of revenue in contracts with government or state-funded entities.
• Potential need for additional future financing.
• Ability to manage growth and expand operations.
• Reliance on strategic partners and other third parties.
• Ability to maintain, protect, and defend intellectual property rights.
• Risks associated with privacy, data protection, or cybersecurity incidents and related regulations.
• Uncertainty or changes with respect to laws and regulations, taxes, trade conditions, and the macroeconomic environment.
• The combined company's ability to maintain internal control over financial reporting and operate as a public company.
• The possibility that required regulatory approvals for the proposed transaction are delayed or not obtained.
• The risk that shareholders could elect to have their shares redeemed, leaving the combined company with insufficient cash (though this risk was largely mitigated by the low redemption rate in this specific filing).
• The occurrence of any event, change, or other circumstance that could give rise to the termination of the business combination agreement.
• The outcome of any legal proceedings or government investigations that may be commenced against Infleqtion or Churchill.
• Failure to realize the anticipated benefits of the proposed transaction.
• The ability of Churchill or the combined company to issue equity or equity-linked securities in connection with the proposed transaction or in the future.
• No assurance that the NYSE listing condition will be met, which could prevent consummation of the Business Combination unless waived.

Future Outlook

Infleqtion expects to be well capitalized at closing, combining the Churchill X proceeds with existing cash on hand to support continued execution. This strengthened balance sheet is anticipated to accelerate Infleqtion's technology roadmap and product commercialization, expanding deployments across artificial intelligence, national security, and space, while enabling additional real-world applications. The company aims to increase in value and maintain, protect, and enhance its intellectual property.

Management Comments

• The strong support from Churchill X’s shareholders is expected to result in Infleqtion receiving over $550 million of gross proceeds, including nearly 100% of the cash held in Churchill X’s trust account prior to the redemption deadline and more than $125 million of incremental capital raised through a common stock PIPE.
• Infleqtion expects to be well capitalized at closing, combining the Churchill X Proceeds with existing cash on hand to support continued execution.
• The strengthened balance sheet is expected to accelerate Infleqtion’s technology roadmap and product commercialization, expanding deployments across artificial intelligence, national security, and space while enabling additional real-world applications.

Industry Context

StockSavvy.ai notes that Infleqtion's successful business combination and upcoming NYSE listing position it as the first publicly listed neutral-atom quantum technology company and the only public company with commercial leadership across both quantum computing and precision sensing. This move signifies a maturing of the quantum technology sector, bringing a specialized player to public markets at a time of increasing interest in advanced computing and sensing capabilities for AI, national security, and space applications.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results for a detailed assessment against global benchmarks.
• Infleqtion's emergence as the first publicly listed neutral-atom quantum technology company suggests it is a pioneer in a niche, high-growth segment, making direct comparisons challenging with established industry standards.

Management Changes

Corporate Governance

Legal Proceedings

• The filing mentions "the outcome of any legal proceedings or government investigations that may be commenced against Infleqtion or Churchill" as a forward-looking risk, but does not detail any current or ongoing legal proceedings.

Stakeholder Impact

• Shareholders (Churchill X): Existing shareholders will receive shares of common stock in the newly formed Delaware entity, Infleqtion, Inc., replacing their Cayman Islands ordinary shares. Those who redeemed received approximately $10.27 per share.
• Shareholders (Infleqtion): Existing Infleqtion stockholders participated in the PIPE, demonstrating continued commitment, and will now be shareholders in a publicly traded company.
• Employees (Infleqtion): The approval of an Incentive Plan and an Employee Stock Purchase Plan (ESPP) provides mechanisms for equity compensation and employee ownership, potentially enhancing retention and motivation.
• Customers/Partners (Infleqtion): A strengthened balance sheet and public listing may enhance Infleqtion's credibility and capacity to deliver on contracts, particularly with government and state-funded entities.
• Creditors: The significant capital infusion strengthens the company's financial position, potentially reducing credit risk.

Next Steps

• Closing of the Business Combination, expected on February 13, 2026.
• Deregistration from Cayman Islands and domestication to Delaware.
• Renaming of the continuing entity to Infleqtion, Inc.
• Delisting of Churchill X shares, warrants, and units from Nasdaq.
• Listing of Infleqtion, Inc. common stock and warrants on the New York Stock Exchange (NYSE) under symbols INFQ and INFQ WS, respectively, starting February 17, 2026.
• Acceleration of Infleqtion's technology roadmap and product commercialization.
• Expansion of deployments across artificial intelligence, national security, and space.

Key Dates

Recommendation

The overwhelming shareholder approval, coupled with an exceptionally low redemption rate and a substantial capital infusion of over $550 million, provides Infleqtion with a robust financial foundation to execute its technology roadmap and commercialization strategy. Becoming the first publicly listed neutral-atom quantum technology company with leadership in both quantum computing and precision sensing positions it uniquely in a high-growth, emerging market. The NYSE listing further enhances its profile and liquidity, making it an attractive investment for those seeking exposure to cutting-edge quantum advancements.

Keywords

Quantum Technology, Quantum Computing, Quantum Sensing, Infleqtion, Churchill Capital Corp X, SPAC, Merger, Business Combination, NYSE Listing, Neutral-Atom Technology, Artificial Intelligence, National Security, Space